SULINDAC
Active substance: sulindac
TABLET · SULINDAC 200 mg/1
United StatesActive
Marketing holder: PuraCap Laboratories LLC dba Blu Pharmaceuticals
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- SULINDAC · 200 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-3264-7537-a145-f7297c4a81c2,01a1208c-4d70-7a8f-a9fc-e84c376f39a7,01a1208d-17b8-70e7-bf86-afe69654be71,01a1208d-4378-7a80-9c95-8f74595a6c41,01a12090-e8ae-7818-8b44-5a83710fe5b9;count=14 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 24658-771
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 24658-771 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 24658-771 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 24658-771 · Verified 2026-10-09 · open in source